Payer Challenges and Issues in the Management of OAB: Improving Patient Outcomes with Optimal Cost and Treatment Strategies.

Detalles Bibliográficos
Publicado en:Journal of Managed Care Medicine Vol. 21; no. 4; pp. 64 - 69
Autor principal: Comiter, Craig V.
Formato: tables/charts Journal Article
Publicado: National Association of Managed Care Physicians, Inc. 2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133475821&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 133475821
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10941525
        9084
      jtl: Journal of Managed Care Medicine
      issn: 10941525
      maglogo: N
    pubinfo:
      dt: 2018
      vid: 21
      iid: 4
      pid: 54351
      pub: National Association of Managed Care Physicians, Inc.
      place: Glen Allen, Virginia
    artinfo:
      ui:
        133475821
        133475821
        133475821
        133475821
      ppf: 64
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Payer Challenges and Issues in the Management of OAB: Improving Patient Outcomes with Optimal Cost and Treatment Strategies.
      aug:
        au: Comiter, Craig V.
        affil: Associate Professor in the Department of Urology and the Department of Obstetrics and Gynecology at Stanford University School of Medicine, Stanford, CA
      sug:
        subj:
          Overactive Bladder Therapy
          Disease Management
          Health Care Costs
          Treatment Outcomes
          Behavior Therapy
          Urge Incontinence
          Overactive Bladder Symptoms
          Nerve Block
          Adrenergic Agonists Therapeutic Use
          Adverse Drug Event
          Adrenergic Agonists Adverse Effects
          Oxybutynin Therapeutic Use
          Muscarinic Antagonists Therapeutic Use
          Blood-Brain Barrier
          Drug Interactions
          Treatment Termination
          Quality-Adjusted Life Years
          Vagal Stimulation
          Botulinum Toxins Therapeutic Use
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N